• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of gene therapy and its effect to hypothalamic-pituitary-adrenal axis

Research Project

Project/Area Number 14570711
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionHOKKAIDO UNIVERSITY

Principal Investigator

TAJIMA Toshihiro  Hokkaido Univ., Grad.School of Med., Inst., 大学院・医学研究科, 助手 (50333597)

Co-Investigator(Kenkyū-buntansha) OKADA Tadashi  Jichi Medi School., Inst., 医学部, 助手 (00326828)
ARIGA Tadashi  Hokkaido Univ., Grad.School of Med., Corporate Donated Chair Teacher., 大学院・医学研究科, 寄附講座教員 (60322806)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2003: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2002: ¥1,100,000 (Direct Cost: ¥1,100,000)
KeywordsCAH / Gene therapy / Adenovirus vector / Hypothalamus / Pituitary / 21水酸化酵素 / ACTH
Research Abstract

We studied the feasibility of gene therapy was studied using 21-OH deficient mice and a replication-deficient adenovirus system. Intra-adrenal injection of adenovirus-human 21-OH gene vector induced mRNA with highest expression from 2 to 7 days before a gradual decline. After injection, plasma corticosterone level did not significantly after 4days, but increased to similar level to these in wild type mice by 7,14, and 30 days. Adrenal morphology of 21-OH deficient mice showed lack of zonation, and hypertrophy and hyperplasia of adrenocortical mitochondria with few tubulovesicular christae. These morphological abnormalities were markedly improved 7 days after gene delivery. Plasma corticosterone increased from undetectable level to values similar in wild type mice by 7 and 14 days, declining over the next 40 days.
To determine whether hypothalamic-pituitary axis was normalized by gene delivery and subsequent increase of corticosterone, mRNA levels of POMC in pituitary was analyzed by in situ hybridization. As results, mRNA levels of POMC was not suppressed after gene delivery. Reflecting this, serum progesterone, that is precursor steroid of corticosterone remained high after gene delivery. These findings indicate that more stable induction of 21-hydroxylase activity may be required to normalize hypothalamic-pituitary axis in 21-OH deficient mice.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] 小川 英伸: "新生児マススクリーニング実施後に見られた先天性副腎過形成症死亡例の調査"日本小児科学会雑誌. 107. 1003-1006 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ogawa Eishin: "Mortality in patients with congenital 21-hydroxylase deficiency diagnosed after the induction of a newborn screening in Japan"clinical Pediatric Endocrinology. 12. 19-23 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujieda Kenji: "Molecular pathogenesis of lipoid adrenal hyperplasia and adrenal hypoplasia congenita"Journal of Steroid Biochemistry and Molecular Biology. 85. 483-489 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Christa Fluck: "Mutations in NADPH-cytochrome P450 oxidoreductase in patients with multiple steroidogenic defects with and without associated with Antley-Bixler syndrome."Nature Genetics. 36. 228-230 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] OGAWA EISIN: "Mortality in patients with congenital 21-hydroxylase deficiency diagnosed after the induction of a newborn screening in Japan"Japanese Journal of Pediatrica. 107. 1003-1006 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] OGAWA EISIN: "Mortality in patients with congenital 21-hydroxylase deficiency diagnosed after the induction of a newborn screening in Japan"Clinical Pediatric Endocrinology. 12. 19-23 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] FUJIEDA KENJI: "Moleculai pathogenesis of lipoid adrenal hyperplasia and adrenal hypoplasia congenita"Journal of Steroid Biochemistry and Molecular Biology. 85. 483-489 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] CHRISTA FLUCK: "Mutations in NADPH-cytochrome P450 oxidoreductase in patients with multiple steroidogenic defects with and without associated with Antley-Bixler syndrome."Nature Genetics. 36. 228-230 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小川 英伸: "新生児マススクリーニング実施後に見られた先天性副腎過形成症死亡例の調査"日本小児科学会雑誌. 107. 1003-1006 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ogawa Eisin: "Mortality in patients with congenital 21-hydroxylase deficiency, diagnosed after the induction of a newborn screening in Japan"Clinical Pediatric Endocrinology. 12. 19-23 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Fujieda Kenji: "Molecular pathogenesis of lipoid adrenal hyperplasia and adrenal hypoplasia congenita"Journal of Steroid Biochemistry and Molecular Biology. 85. 483-489 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Christa Fluck: "Mutations in NADPH-cytochrome P450 oxidoreductase in patients with multiple steroidogenic defects with and without associated with Antley-Bixler syndrome"Nature Genetics. 36. 228-230 (2004)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi